Roche Launches 7-Minute Immunotherapy Injection for Lung Cancer in India
Revolutionizing Cancer Care Delivery Roche Pharma India has officially launched its subcutaneous form of the blockbuster immunotherapy drug Tecentriq (atezolizumab) in India, offering a rapid, seven-minute injection for lung cancer patients. This medical milestone, introduced this month, seeks to replace the traditional intravenous (IV) infusion method, which typically requires 30 to 60 minutes or longer…